Cargando...
Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
Type 2 diabetes mellitus (T2DM) management is complex, with few patients successfully achieving recommended glycemic targets with monotherapy, most progressing to combination therapy, and many eventually requiring insulin. Sodium glucose cotransporter 2 (SGLT2) inhibitors are an emerging class of an...
Gardado en:
| Publicado en: | Drugs Context |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Just Medical Media Limited
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4654596/ https://ncbi.nlm.nih.gov/pubmed/26633984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212288 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|